These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. Shah PP; Mashru RC AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657 [TBL] [Abstract][Full Text] [Related]
4. Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases: Marzouk MA; Darwish MK; Abd El-Fattah MA Drug Dev Ind Pharm; 2020 Mar; 46(3):395-402. PubMed ID: 31996053 [No Abstract] [Full Text] [Related]
5. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. Douroumis DD; Gryczke A; Schminke S AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510 [TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet. Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705 [TBL] [Abstract][Full Text] [Related]
7. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES. Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438 [TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates. Preis M; Grother L; Axe P; Breitkreutz J Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543 [TBL] [Abstract][Full Text] [Related]
9. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use. Mahesh A; Shastri N; Sadanandam M Curr Drug Deliv; 2010 Jan; 7(1):21-7. PubMed ID: 19863484 [TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656 [TBL] [Abstract][Full Text] [Related]
11. Cetirizine release from cyclodextrin formulated compressed chewing gum. Stojanov M; Larsen KL Drug Dev Ind Pharm; 2012 Sep; 38(9):1061-7. PubMed ID: 22185653 [TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins. Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111 [TBL] [Abstract][Full Text] [Related]
14. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches. Rahman Z; Zidan AS; Berendt RT; Khan MA Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447 [TBL] [Abstract][Full Text] [Related]
15. Original research paper. Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying. Amelian A; Szekalska M; Ciosek P; Basa A; Winnicka K Acta Pharm; 2017 Mar; 67(1):113-124. PubMed ID: 28231047 [TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. Patel AR; Vavia PR AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648 [TBL] [Abstract][Full Text] [Related]
17. Study of the inclusion complexes formed between cetirizine and α-, β-, and γ-cyclodextrin and evaluation on their taste-masking properties. Stojanov M; Wimmer R; Larsen KL J Pharm Sci; 2011 Aug; 100(8):3177-3185. PubMed ID: 21394723 [TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
19. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression. Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465 [TBL] [Abstract][Full Text] [Related]
20. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]